NLSP 424B3 DEF-14A Report Sept. 10, 2025 | Alphaminr
NLS Pharmaceutics Ltd.

NLSP 424B3 Report ended Sept. 10, 2025

NLS PHARMACEUTICS LTD.
CIK: 1783036
Filing Type: 424B3
Report Date: 2025-09-10
Download URL: https://www.sec.gov/Archives/edgar/data/1783036/000121390025086600/ea0226019-15.htm
]]>
TABLE OF CONTENTS